Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report

Haruna Yoshikawa; Takeshi Sato; Takahiro Ishikawa; Jumpei Ito; Fumito Yamazaki; Haruko Shima; Misa Honda; Hironori Shibata; Tomohiro Ishii; Hiroshi Asanuma; Hiroyuki Shimada; Tomonobu Hasegawa

doi:10.1002/pbc.29368

Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report

Haruna Yoshikawa, Takeshi Sato, Takahiro Ishikawa, Jumpei Ito, Fumito Yamazaki, Haruko Shima, Misa Honda, Hironori Shibata, Tomohiro Ishii, Hiroshi Asanuma, Hiroyuki Shimada, Tomonobu Hasegawa

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e29368
Journal	Pediatric Blood and Cancer
Volume	69
Issue number	2
DOIs	https://doi.org/10.1002/pbc.29368
Publication status	Published - 2022 Feb

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.29368

Cite this

@article{9e12b3aa0ce746cbab884a13bc244c75,

title = "Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report",

author = "Haruna Yoshikawa and Takeshi Sato and Takahiro Ishikawa and Jumpei Ito and Fumito Yamazaki and Haruko Shima and Misa Honda and Hironori Shibata and Tomohiro Ishii and Hiroshi Asanuma and Hiroyuki Shimada and Tomonobu Hasegawa",

note = "Funding Information: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd. The other authors declare no conflict of interest. Funding Information: informationNovo Nordisk Pharma Ltd.; JCR Pharmaceuticals Co., Ltd.We thank the patient's family for participating in this study.",

year = "2022",

month = feb,

doi = "10.1002/pbc.29368",

language = "English",

volume = "69",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors

T2 - A case report

AU - Yoshikawa, Haruna

AU - Sato, Takeshi

AU - Ishikawa, Takahiro

AU - Ito, Jumpei

AU - Yamazaki, Fumito

AU - Shima, Haruko

AU - Honda, Misa

AU - Shibata, Hironori

AU - Ishii, Tomohiro

AU - Asanuma, Hiroshi

AU - Shimada, Hiroyuki

AU - Hasegawa, Tomonobu

N1 - Funding Information: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd. The other authors declare no conflict of interest. Funding Information: informationNovo Nordisk Pharma Ltd.; JCR Pharmaceuticals Co., Ltd.We thank the patient's family for participating in this study.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85115358410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115358410&partnerID=8YFLogxK

U2 - 10.1002/pbc.29368

DO - 10.1002/pbc.29368

M3 - Letter

C2 - 34558169

AN - SCOPUS:85115358410

SN - 1545-5009

VL - 69

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 2

M1 - e29368

ER -

Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this